A reversed-phase, high-performance liquid chromatographic (HPLC) procedure, which is specific and quantitative for lidocaine hydrochloride, epinephrine, and methylparaben, was developed for the analysis of lidocaine hydrochloride and lidocaine hydrochloride with epinephrine solutions for injection.
Stability-indicating assay for chlorthalidone formulation: Evaluation of the USP analysis and a high-performance liquid chromatographic analysis
β Scribed by John Bauer; John Quick; Suzanne Krogh; Douglas Shada
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 381 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
β¦ Synopsis
An investigation of the USP assay of chlorthalidone tablets showed that variable degradation of chlorthalidone occurred during assay preparation. The degradation products were isolated and identified. A stability-indicating high-performance liquid chromatographic (HPLC) assay which separates the degradation products from chlorthalidone was developed and used to examine the present USP preparation. The HPLC assay is suggested as an alternate.
Keyphrases Chlorthalidone-high-performance liquid chromatography, stability-indicating assay, comparison with the USP analysis 0 Degradation products-of chlorthalidone, high-performance liquid chromatographic determination, comparison with the USP analysis 0 USP analysis-for chlorthalidone and degradation products, comparison to a high-performance liquid chromatographic assay Chlorthalidone (I) is a monosulfamyl diuretic used in the treatment of hypertension. The official analysis of chlorthalidone tablets, as prescribed in the United States Pharmacopeia, is a spectrophotometric assay (1). Chlorthalidone has been quantitated in various media using a variety of methodologies (2-8). The major techniques in
π SIMILAR VOLUMES
## Abstract Two sensitive and reproducible methods were developed and validated for the determination of ziprasidone (ZIP) in the presence of its degradation products in pure form and in pharmaceutical formulations. The ο¬rst method was based on reversedβphase highβperformance liquid chromatography